SDGR

SEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · derivative · entry 7

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,862

Underlying: Common Stock · 14,892 shares

Expires 2028-11-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F6 · derivative.exercise_date: The option was granted on November 29, 2018 and is fully vested.

SEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · derivative · entry 6

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 108 shares

Expires 2026-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F5 · derivative.exercise_date: The option was granted on May 10, 2016 and is fully vested.

SEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · nonDerivative · entry 3

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,721

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(3) of this Form 4.

F2 · balance_after: Includes 7,590 unvested RSUs

SEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · nonDerivative · entry 2

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F2 · balance_after: Includes 7,590 unvested RSUs

SEC source: 0001490978-23-000059 · wk-form4_1684963170.xml · nonDerivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP, CLO & CPO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,829

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F2 · balance_after: Includes 7,590 unvested RSUs

SEC source: 0001490978-23-000014 · wf-form4_167606653003833.xml · derivative · entry 2

Lorton Kenneth Patrick · CIK 0001797730 · EVP & Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,000

Underlying: Common Stock · 49,000 shares

Expires 2033-02-09

F3 · derivative.exercise_date: The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

SEC source: 0001490978-23-000014 · wf-form4_167606653003833.xml · nonDerivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP & Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,388

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on February 9, 2023 and will vest in equal installments on each of February 9, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 8,170 unvested RSUs.

SEC source: 0001490978-23-000016 · wf-form4_167606662057112.xml · derivative · entry 2

Tran Yvonne · CIK 0001797777 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,525

Underlying: Common Stock · 45,525 shares

Expires 2033-02-09

F3 · derivative.exercise_date: The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

SEC source: 0001490978-23-000016 · wf-form4_167606662057112.xml · nonDerivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,721

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on February 9, 2023 and will vest in equal installments on each of February 9, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 7,590 unvested RSUs.

SEC source: 0001490978-23-000015 · wf-form4_167606657858733.xml · derivative · entry 1

Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,735

Underlying: Common Stock · 54,735 shares

Expires 2033-02-09

F1 · derivative.exercise_date: The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

SEC source: 0001490978-23-000013 · wf-form4_167606648646049.xml · derivative · entry 2

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,000

Underlying: Common Stock · 13,000 shares

Expires 2033-02-09

F3 · derivative.exercise_date: The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

SEC source: 0001490978-23-000013 · wf-form4_167606648646049.xml · nonDerivative · entry 1

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,003

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on February 9, 2023 and will vest in equal installments on each of February 9, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 8,000 unvested RSUs.

SEC source: 0001490978-23-000012 · wf-form4_167606643944365.xml · derivative · entry 2

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,525

Underlying: Common Stock · 65,525 shares

Expires 2033-02-09

F2 · derivative.exercise_date: The option was granted on February 9, 2023. The exercise price per share is equal to 110% of the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

SEC source: 0001490978-23-000012 · wf-form4_167606643944365.xml · derivative · entry 1

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,960

Underlying: Common Stock · 84,960 shares

Expires 2033-02-09

F1 · derivative.exercise_date: The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

SEC source: 0001490978-23-000011 · wf-form4_167606638377104.xml · derivative · entry 1

Akinsanya Karen · CIK 0001797672 · President of R&D, Therapeutics

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,270

Underlying: Common Stock · 63,270 shares

Expires 2033-02-09

F1 · derivative.exercise_date: The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

SEC source: 0001490978-23-000010 · wf-form4_167606634889763.xml · derivative · entry 2

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,270

Underlying: Common Stock · 63,270 shares

Expires 2033-02-09

F3 · derivative.exercise_date: The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

SEC source: 0001490978-23-000010 · wf-form4_167606634889763.xml · nonDerivative · entry 1

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,545

F1 · security: Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on February 9, 2023 and will vest in equal installments on each of February 9, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continued service with the company.

F2 · balance_after: Includes 10,545 unvested RSUs.

SEC source: 0001490978-23-000004 · wf-form4_167545899115176.xml · derivative · entry 5

Tran Yvonne · CIK 0001797777 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108

Underlying: Common Stock · 13,269 shares

Expires 2026-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F4 · derivative.exercise_date: The option was granted on May 11, 2016 and is fully vested.

SEC source: 0001490978-23-000004 · wf-form4_167545899115176.xml · derivative · entry 4

Tran Yvonne · CIK 0001797777 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,731 shares

Expires 2027-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F3 · derivative.exercise_date: The option was granted on June 1, 2017 and is fully vested.

SEC source: 0001490978-23-000004 · wf-form4_167545899115176.xml · nonDerivative · entry 3

Tran Yvonne · CIK 0001797777 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,131

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.00 to $27.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote(2) of this Form 4.

SEC source: 0001490978-23-000004 · wf-form4_167545899115176.xml · nonDerivative · entry 2

Tran Yvonne · CIK 0001797777 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,131

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

SEC source: 0001490978-23-000004 · wf-form4_167545899115176.xml · nonDerivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

SEC source: 0001490978-23-000002 · wf-form4_167295515936956.xml · derivative · entry 3

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 66,886 shares

Expires 2023-01-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F3 · derivative.exercise_date: The option was granted on January 8, 2013 and is fully vested.

SEC source: 0001490978-23-000002 · wf-form4_167295515936956.xml · nonDerivative · entry 2

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,432

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.04 to $18.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote(2) of this form 4.

SEC source: 0001490978-23-000002 · wf-form4_167295515936956.xml · nonDerivative · entry 1

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 251,318

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2022.

SEC source: 0001209191-22-046691 · doc4.xml · derivative · entry 1

Porges Geoffrey Craig · CIK 0001938826 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common Stock · 180,000 shares

Expires 2032-08-18

F1 · derivative.exercise_date: The option was granted on August 18, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on August 18, 2023 and the remainder are scheduled to vest in equal monthly installments through August 18, 2026.

SEC source: 0001209191-22-045632 · doc4.xml · derivative · entry 3

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,870

Underlying: Common Stock · 4,950 shares

Expires 2029-12-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.

F2 · derivative.exercise_date: The option was granted on December 2, 2019. The shares underlying the option vested with respect to 25% of the shares on December 2, 2020 and the remainder vest in equal monthly installments through December 2, 2023.

SEC source: 0001209191-22-045632 · doc4.xml · nonDerivative · entry 2

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.

SEC source: 0001209191-22-045632 · doc4.xml · nonDerivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.

SEC source: 0001209191-22-037481 · doc4.xml · derivative · entry 1

Chodakewitz Jeffrey · CIK 0001610876 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,907

Underlying: Common Stock · 14,907 shares

Expires 2032-06-15

F1 · derivative.exercise_date: The option was granted on June 15, 2022. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001209191-22-037491 · doc4.xml · derivative · entry 1

Thornberry Nancy · CIK 0001797826 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,907

Underlying: Common Stock · 14,907 shares

Expires 2032-06-15

F1 · derivative.exercise_date: The option was granted on June 15, 2022. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001209191-22-037490 · doc4.xml · derivative · entry 1

Friesner Richard · CIK 0001798426 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,907

Underlying: Common Stock · 14,907 shares

Expires 2032-06-15

F1 · derivative.exercise_date: The option was granted on June 15, 2022. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001209191-22-037489 · doc4.xml · derivative · entry 1

Lynton Michael · CIK 0001606115 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,907

Underlying: Common Stock · 14,907 shares

Expires 2032-06-15

F1 · derivative.exercise_date: The option was granted on June 15, 2022. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001209191-22-037487 · doc4.xml · derivative · entry 1

Kapeller-Libermann Rosana · CIK 0001797835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,907

Underlying: Common Stock · 14,907 shares

Expires 2032-06-15

F1 · derivative.exercise_date: The option was granted on June 15, 2022. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001209191-22-037485 · doc4.xml · derivative · entry 1

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,907

Underlying: Common Stock · 14,907 shares

Expires 2032-06-15

F1 · derivative.exercise_date: The option was granted on June 15, 2022. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001209191-22-037483 · doc4.xml · derivative · entry 1

GINSBERG GARY L · CIK 0001236136 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,907

Underlying: Common Stock · 14,907 shares

Expires 2032-06-15

F1 · derivative.exercise_date: The option was granted on June 15, 2022. The award shall vest on the twelve-month anniversary of the date of grant of the award (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the award), subject to continued service.

SEC source: 0001209191-22-030525 · doc4.xml · derivative · entry 1

OBEROI ARUN · CIK 0001275887 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,223

Underlying: Common Stock · 30,223 shares

Expires 2032-05-17

F1 · derivative.exercise_date: The option was granted on May 17, 2022. The shares underlying the option are scheduled to vest in equal yearly installments through May 17, 2025, subject to continued service.

SEC source: 0001209191-22-008274 · doc4.xml · derivative · entry 1

Lorton Kenneth Patrick · CIK 0001797730 · EVP & Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The option was granted on February 9, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2023 and the remainder are scheduled to vest in equal monthly installments through February 9, 2026.

SEC source: 0001209191-22-008275 · doc4.xml · derivative · entry 1

Herman Jenny · CIK 0001797785 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The option was granted on February 9, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2023 and the remainder are scheduled to vest in equal monthly installments through February 9, 2026.

SEC source: 0001209191-22-008273 · doc4.xml · derivative · entry 1

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The option was granted on February 9, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2023 and the remainder are scheduled to vest in equal monthly installments through February 9, 2026.

SEC source: 0001209191-22-008272 · doc4.xml · derivative · entry 1

Akinsanya Karen · CIK 0001797672 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The option was granted on February 9, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2023 and the remainder are scheduled to vest in equal monthly installments through February 9, 2026.

SEC source: 0001209191-22-008271 · doc4.xml · derivative · entry 1

Farid Ramy · CIK 0001797707 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 215,000

Underlying: Common Stock · 215,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The option was granted on February 9, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2023 and the remainder are scheduled to vest in equal monthly installments through February 9, 2026.

SEC source: 0001209191-22-008270 · doc4.xml · derivative · entry 1

Tran Yvonne · CIK 0001797777 · EVP & Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2032-02-09

F1 · derivative.exercise_date: The option was granted on February 9, 2022. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2023 and the remainder are scheduled to vest in equal monthly installments through February 9, 2026.

SEC source: 0001209191-21-069493 · doc4.xml · derivative · entry 4

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,756

Underlying: Common Stock · 15,601 shares

Expires 2030-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.

F4 · derivative.exercise_date: This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.

SEC source: 0001209191-21-069493 · doc4.xml · nonDerivative · entry 3

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.78 to $36.99, inclusive.

SEC source: 0001209191-21-069493 · doc4.xml · nonDerivative · entry 2

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,900

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.77 to $36.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3) of this Form 4.

SEC source: 0001209191-21-069493 · doc4.xml · nonDerivative · entry 1

Abel Robert Lorne · CIK 0001798179 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,601

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.

SEC source: 0001209191-21-060945 · doc4.xml · derivative · entry 3

Akinsanya Karen · CIK 0001797672 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,198

Underlying: Common Stock · 1,393 shares

Expires 2028-11-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2021.

F2 · derivative.exercise_date: This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.

SEC source: 0001209191-21-060945 · doc4.xml · nonDerivative · entry 2

Akinsanya Karen · CIK 0001797672 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2021.

SEC source: 0001209191-21-060945 · doc4.xml · nonDerivative · entry 1

Akinsanya Karen · CIK 0001797672 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 2, 2021.